tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2021 Dec 21;10(1):5.
doi: 10.3390/vaccines10010005.
The Potential Benefits of the Influenza Vaccination on COVID-19 Mortality Rate-A Retrospective Analysis of Patients in Poland
Kinga Izabela Stańczak-Mrozek[SUP] 1 [/SUP], Adam Sobczak[SUP] 1 [/SUP], Leszek Lipiński[SUP] 1 [/SUP], Elżbieta Sienkiewicz[SUP] 2 [/SUP], Dorota Makarewicz[SUP] 1 [/SUP], Roman Topór-Mądry[SUP] 3 [/SUP], Jarosław Pinkas[SUP] 4 [/SUP], Radosław Adam Sierpiński[SUP] 1 [/SUP]
Affiliations
Abstract
In this study,we used publicly available data from the Centrum e-Zdrowia (CeZ) Polish Databank proposing a possible correlation between influenza vaccination and mortality due to COVID-19. We limited our search to the patients with positive COVID‑19 laboratory tests from 1 January 2020 to 31 March 2021 and who filled a prescription for any influenza vaccine during the 2019-2020 influenza season. In total, we included 116,277 patients and used a generalized linear model to analyze the data.We found out that patients aged 60+ who received an influenza vaccination have a lower probability of death caused by COVID-19 in comparison to unvaccinated, and the magnitude of this difference grows with age. For people below 60 years old, we did not observe an influence of the vaccination. Our results suggest a potential protective effect of the influenza vaccine on COVID-19 mortality of the elderly. Administration of the influenza vaccine before the influenza season would reduce the burden of increased influenza incidence, the risk of influenza and COVID‑19 coinfection and render the essential medical resources accessible to cope with another wave of COVID-19. To our knowledge, this is the first study showing a correlation between influenza vaccination and the COVID-19 mortality rate in Poland.
Keywords: COVID-19; cross-protection; influenza vaccine; prevention.
. 2021 Dec 21;10(1):5.
doi: 10.3390/vaccines10010005.
The Potential Benefits of the Influenza Vaccination on COVID-19 Mortality Rate-A Retrospective Analysis of Patients in Poland
Kinga Izabela Stańczak-Mrozek[SUP] 1 [/SUP], Adam Sobczak[SUP] 1 [/SUP], Leszek Lipiński[SUP] 1 [/SUP], Elżbieta Sienkiewicz[SUP] 2 [/SUP], Dorota Makarewicz[SUP] 1 [/SUP], Roman Topór-Mądry[SUP] 3 [/SUP], Jarosław Pinkas[SUP] 4 [/SUP], Radosław Adam Sierpiński[SUP] 1 [/SUP]
Affiliations
- PMID: 35062666
- DOI: 10.3390/vaccines10010005
Abstract
In this study,we used publicly available data from the Centrum e-Zdrowia (CeZ) Polish Databank proposing a possible correlation between influenza vaccination and mortality due to COVID-19. We limited our search to the patients with positive COVID‑19 laboratory tests from 1 January 2020 to 31 March 2021 and who filled a prescription for any influenza vaccine during the 2019-2020 influenza season. In total, we included 116,277 patients and used a generalized linear model to analyze the data.We found out that patients aged 60+ who received an influenza vaccination have a lower probability of death caused by COVID-19 in comparison to unvaccinated, and the magnitude of this difference grows with age. For people below 60 years old, we did not observe an influence of the vaccination. Our results suggest a potential protective effect of the influenza vaccine on COVID-19 mortality of the elderly. Administration of the influenza vaccine before the influenza season would reduce the burden of increased influenza incidence, the risk of influenza and COVID‑19 coinfection and render the essential medical resources accessible to cope with another wave of COVID-19. To our knowledge, this is the first study showing a correlation between influenza vaccination and the COVID-19 mortality rate in Poland.
Keywords: COVID-19; cross-protection; influenza vaccine; prevention.